CARsgen Therapeutics Holdings Limited (stock code: 02171) submitted a Next Day Disclosure Return on 23 January 2026, detailing changes in issued shares and treasury shares. According to the announcement, the opening balance as of 30 November 2025 stood at 574,242,655 issued shares (excluding treasury shares) and 3,730,500 treasury shares.

On 1 December 2025, the company repurchased 173,500 shares, bringing the number of issued shares (excluding treasury shares) to 574,069,155 and the treasury share count to 3,904,000. The total number of shares remained at 577,973,155. The repurchase price per share averaged HKD 17.0833, and a subsequent revision placed the aggregate repurchase price at HKD 2,963,950, with the lowest repurchase price per share at HKD 17.03.

The report also highlighted earlier repurchases for cancellation, including 250,000 shares on 21 October 2025 and 205,000 shares on 23 October 2025, which had not been cancelled as of the closing balance date. The total number of shares authorized for repurchase under the resolution dated 22 May 2025 was 57,543,590, and the period for issuing new shares or transferring treasury shares was set to continue until 31 December 2025.